Sentence examples for most recent therapy from inspiring English sources

At his most recent therapy appointment with Mr. Bressem, Mr. Van Cott started by discussing why he'd stomped out of their previous session angry.

Kimberly Brusk, a domestic violence survivor in Atlanta, said she spent half of her most recent therapy session discussing Trump and how he is reminiscent of her ex.

Patients must have received ≥3 prior regimens, must be responsive to at least 1 line of therapy, and be refractory to their most recent therapy.

Even with the most recent therapy, liraglutide in monotherapy, the American Diabetes Association's HbA1c goal of <7% was reached only in the 51% of patients with the highest daily dose of 1.8 mg (8).

All of the patients had received at least one prior taxane-containing regimen (31% had at least two regimens), and 98% of patients had a taxane-containing regimen as their most recent therapy in the metastatic setting.

The primary objective of the study is to compare OS in patients with relapsed and refractory MM shown to be refractory to their most recent therapy and who have received all standard approved therapies, randomized to receive carfilzomib or a defined BSC regimen.

Most recent therapies involve direct injection of cells into the damaged heart tissue to induce regeneration and help restore its functions, however, anoikis and the harsh environment at the sight of injection limit the therapeutic efficacy of current techniques.

There was no upper limit to the number of prior therapies patients may have received, although patients must have had disease progression during or since their most recent systemic therapy.

Seventeen (27%) of these patients received darbepoetin alfa as their most recent ESA therapy, with a mean (SD) dose of 232 (53) μg.

In the paper by Cunningham et al (2004) patients received irinotecan at the same dose and schedule as that given during their most recent prestudy therapy.

In patients with longer time intervals, this was primarily a function of relatively prolonged control or indolent tumor growth after discontinuation of their most recent prior therapy.